Up to 25% of new mothers suffer from postpartum depression, which can significantly impact their parenting behavior and the wellbeing of their children.
Kymera seeks to raise $225M; Adcendo, Multitude’s new ADC deal
Plus, news about Talus Bioscience, Moleculin, Organon and Eli Lilly: Kymera Therapeutics aims to raise $225M: The public offering will be … Sign up to